Terms: = Bone cancer AND TG, Thyroglobulin AND Treatment
174 results:
1. Radioactive iodine therapy for follicular thyroid cancer: a 15 years follow-up study of Chinese patients.
Shi H; Yang B; Feng JI; Li JH; Cheng X; Li YJ; Fu Y; Xu XD; Qian LH; Tang LJ; Liu W
Nucl Med Commun; 2024 Mar; 45(3):169-174. PubMed ID: 38095140
[TBL] [Abstract] [Full Text] [Related]
2. Automatic planning for head and neck seed implant brachytherapy based on deep convolutional neural network dose engine.
Xiao Z; Xiong T; Geng L; Zhou F; Liu B; Sun H; Ji Z; Jiang Y; Wang J; Wu Q
Med Phys; 2024 Feb; 51(2):1460-1473. PubMed ID: 37757449
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib.
Ling Y; Xiong X; Luo J; Zou Q; Chen P; Pan L; Long M; Feng H; Ouyang W
Front Endocrinol (Lausanne); 2023; 14():1200932. PubMed ID: 37534207
[TBL] [Abstract] [Full Text] [Related]
4. Synergistic anti-cancer and attenuation effects of thymosin on chemotherapeutic drug vinorelbine in tumor-bearing zebrafish.
Wang S; Wei W; Yong H; Zhang Z; Zhang X; Zhang X; Wang S
Biomed Pharmacother; 2023 Jun; 162():114633. PubMed ID: 37018994
[TBL] [Abstract] [Full Text] [Related]
5. The efficacy of adjuvant radioactive iodine after reoperation in patients with persistent or recurrent differentiated thyroid cancer: a systematic review.
Raghupathy J; Tan BKJ; Song HJJMD; Chia AZQ; Tan YZ; Yang SP; Parameswaran R
Langenbecks Arch Surg; 2023 Jan; 408(1):21. PubMed ID: 36635455
[TBL] [Abstract] [Full Text] [Related]
6. The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial.
Karkeet RM; Zekri AN; Sayed-Ahmed MM; Sherif GM; Salem SE; Abdelbary A; Fouad MA; Saad SY
PLoS One; 2022; 17(12):e0278282. PubMed ID: 36480560
[TBL] [Abstract] [Full Text] [Related]
7. ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP.
He Q; Gao H; Chang YL; Wu X; Lin R; Li G; Lin J; Lu H; Chen H; Li Z; Cong Y; Yao J; Liu Z
J Autoimmun; 2022 Oct; 132():102872. PubMed ID: 35926374
[TBL] [Abstract] [Full Text] [Related]
8. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
Front Immunol; 2022; 13():914265. PubMed ID: 35874753
[TBL] [Abstract] [Full Text] [Related]
9. Recovery pattern analysis of swallowing function in patients undergoing total glossectomy and hemiglossectomy.
Deng W; Zhao G; Li Z; Yang L; Xiao Y; Zhang S; Guo K; Xie C; Liang Y; Liao G
Oral Oncol; 2022 Sep; 132():105981. PubMed ID: 35752136
[TBL] [Abstract] [Full Text] [Related]
10. Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report.
Toda S; Kadoya M; Matsui A; Murayama D; Iwasaki H
Ann Palliat Med; 2022 Nov; 11(11):3571-3577. PubMed ID: 35726194
[TBL] [Abstract] [Full Text] [Related]
11. 18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?
Rizzo A; Perotti G; Zagaria L; Lanni V; Racca M; Palestini N; Salvatori M
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):158-166. PubMed ID: 35238517
[TBL] [Abstract] [Full Text] [Related]
12. Head-to-Head Comparison of
Pitalua-Cortes Q; García-Perez FO; Vargas-Ahumada J; Gonzalez-Rueda S; Gomez-Argumosa E; Ignacio-Alvarez E; Soldevilla-Gallardo I; Torres-Agredo L
Front Endocrinol (Lausanne); 2021; 12():794759. PubMed ID: 35002972
[TBL] [Abstract] [Full Text] [Related]
13. Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report.
Toda S; Iwasaki H; Murayama D; Isoda M; Nakayama H; Suganuma N; Masudo K
J Med Case Rep; 2021 Nov; 15(1):556. PubMed ID: 34763724
[TBL] [Abstract] [Full Text] [Related]
14. bone metastasis from noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP); a case report.
Fakhar Y; Khooei A; Aghaee A; Mohammadzadeh Kosari H; Wartofsky L; Zakavi SR
BMC Endocr Disord; 2021 Nov; 21(1):221. PubMed ID: 34736430
[TBL] [Abstract] [Full Text] [Related]
15. Anaplastic Transformation of Differentiated Papillary Thyroid Carcinoma Presenting as Cauda Equina Syndrome.
van Griethuysen JM; Proctor I; Sivabalasingham S
Am J Case Rep; 2021 May; 22():e932002. PubMed ID: 34045430
[TBL] [Abstract] [Full Text] [Related]
16. Validation of the collapsed cone algorithm for HDR liver brachytherapy against Monte Carlo simulations.
Duque AS; van Wagenberg T; Seidensticker M; Streitparth F; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Paiva Fonseca G; Corradini S; Landry G
Brachytherapy; 2021; 20(4):936-947. PubMed ID: 34001415
[TBL] [Abstract] [Full Text] [Related]
17. RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer.
Deandreis D; Maillard A; Zerdoud S; Bournaud C; Vija L; Sajous C; Terroir M; Leenhardt L; Schlumberger M; Borget I; Leboulleux S
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3238-3249. PubMed ID: 33619600
[TBL] [Abstract] [Full Text] [Related]
18. treatment of Differentiated Thyroid cancer and Recurrent Laryngeal Nerve Function with 131 Iodine Based on Positron Emission Tomography/Computed Tomography Image Segmentation Algorithm.
Zhong Y; He J; Zhang C; Ardlee B
World Neurosurg; 2021 May; 149():428-435. PubMed ID: 33166689
[TBL] [Abstract] [Full Text] [Related]
19. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients.
Couto JS; Almeida MFO; Trindade VCG; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RP
Braz J Med Biol Res; 2020; 53(11):e9781. PubMed ID: 33053096
[TBL] [Abstract] [Full Text] [Related]
20. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
[TBL] [Abstract] [Full Text] [Related]
[Next]
